Keybanc analyst Matthew Mishan maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $73 to $60.
Barclays Maintains Equal-Weight on Everbridge, Lowers Price Target to $32
Barclays analyst Ryan Macwilliams maintains Everbridge (NASDAQ:EVBG) with a Equal-Weight and lowers the price target from $40 to $32.